Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Arix Bioscience
Life Sciences
Realising the valuation disconnect
By
Dr Martin Hall
21 Sep 2020
Shield Therapeutics Plc
Life Sciences
Optimism over US deal
By
Dr Martin Hall
18 Sep 2020
City of London Investment Group
Financials
Solid results, with surprise dividend increase
By
Dr Brian Moretta
17 Sep 2020
Diurnal Group Plc
Life Sciences
Closely watching the regulators
By
Dr Martin Hall
17 Sep 2020
Filta Group
Consumer
FOG is lifting
By
Jason Streets
16 Sep 2020
Volta Finance
Financials
Value added by active portfolio management
By
Mark Thomas
15 Sep 2020
Surface Transforms
Industrial
A whole new level of contract winning
By
Mike Foster
15 Sep 2020
Real Estate Credit Investments (RECI)
Investment Companies
Improving returns on new opportunities
By
Mark Thomas
14 Sep 2020
MORhomes
Investment Companies
Low-risk issuer in a low-risk market
By
Mark Thomas
11 Sep 2020
Neodecortech
Consumer
Reassuringly robust
By
Jason Streets
10 Sep 2020
ICG Enterprise Trust
Financials
Defensive growth: explaining downside resilience
By
Mark Thomas
08 Sep 2020
Prev
1
...
40
41
42
43
44
...
84
Next
